The man who predicted the Great Resignation regrets how he quit his first job — here are 3 questions he says you should ask yourself before jumping ship
|
If you believe this has been sent to you in error, please safely unsubscribe.
Key phrases
Older messages
I tried the popular Pomodoro technique to improve my productivity, but it just made it worse — here's why
Thursday, May 26, 2022
The 25-minute work intervals and five-minute breaks made it harder to get in the zone and took longer to get things done, says Jen Glantz. View in browser Business Insider Business Insider Business
I'm a woman and drive for Uber and Lyft. I've made $50,000 in a year and never felt unsafe, despite a lot of drunk passengers.
Wednesday, May 25, 2022
Mhay-Ann Carriza De Felipe, 29, who drives a Tesla, used to share her location with her late husband when working until 2 am View in browser Business Insider Business Insider Business Insider Subscribe
Get ahead of future tech layoffs as a job seeker
Tuesday, May 24, 2022
It's graduation season. Over the past couple of weeks, some 2 million... Read on Insider.com INSIDER INSIDER Subscribe INSIDER FEATURED ARTICLE ENTERPRISE I'm a recruiter. Here are the 3
Meet Jared Birchall, Elon Musk's right-hand man and polar opposite
Tuesday, May 24, 2022
The ex-Morgan Stanley banker's loyalty has few limits, from helping finance the Twitter buy to hiring a PI. View in browser Business Insider Business Insider Business Insider Subscribe Business
Introducing Saved Articles
Monday, May 23, 2022
Save now, read later... View in browser INSIDER INSIDER Subscribe Introducing saved articles We're excited to announce that our new Saved Articles feature is now available! This new feature allow
You Might Also Like
Earnings bulls
Monday, April 22, 2024
Bloomberg Evening Briefing View in browser Bloomberg Robust earnings from corporate America will pull the S&P 500 Index out of its latest morass, despite rising concerns about a significant jump in
👀 Inside the weight-loss drug boom
Monday, April 22, 2024
Buyers saw money in music | Finance's best-kept secret let a little slip | Finimize TOGETHER WITH Hi Reader, here's what you need to know for April 23rd in 3:12 minutes. ☕️ Finimized over a
Who's Afraid of Index Funds?
Monday, April 22, 2024
Plus! Diff Jobs; The Market for Data; Crowded Careers; Black Boxes, Everywhere; Externalities; Intra-Elite Conflict Who's Afraid of Index Funds? By Byrne Hobart • 22 Apr 2024 View in browser View
Rodney's Take 4-22-24 Get Shorties
Monday, April 22, 2024
A Yen for Lower Rates ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
📓 A test for the US economy
Sunday, April 21, 2024
Plus, everything you need to know for the week ahead | Finimize Hi Reader. We've revamped your weekly briefing to give you what you need to know for the week ahead and a recap of the past week. Let
Now’s a good time to diversify your retirement nest egg
Sunday, April 21, 2024
Here's how you could beat inflation and market volatility. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Longreads + Open Thread
Saturday, April 20, 2024
Dennett, Datacenters, Killer Apps, Anthropic, Reading, Thermostats, M&A, Rollups Longreads + Open Thread By Byrne Hobart • 20 Apr 2024 View in browser View in browser Longreads Daniel Dennett has
It’s a great time to make your savings grow
Saturday, April 20, 2024
CDs are making a comeback. Are you coming or what? ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
The economics of uncertainty
Saturday, April 20, 2024
Bloomberg Weekend Reading View in browser Bloomberg The 360-degree view of the world economy this week can be summed up as cautiously optimistic. Or maybe optimistically cautious. Either way, the
Jeff Bezos backs tiny biotech with $130 mil investment
Saturday, April 20, 2024
The following is a third-party sponsored message. It should not be considered a recommendation or endorsement by HS Dent Publishing. Dear Fellow Investor, A little-known biotech has been quietly